Showing results (91-100 of 170) with videos related to

Sort By:
Pageof 17
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|November 1, 1985
[Ototoxicity following the administration of high doses of cisplatin in children with malignant neoplasms]M Stura, G P Perin, G Dini, et al.
Bone Marrow Transplantation|February 16, 1999
Peripheral blood stem cell collection from G-CSF-stimulated unrelated donors for second transplantG Dini, W Arcese, M Barbanti, et al.
The Journal of Hospital Infection|June 29, 2001
Bacillus sphaericus bacteraemia in children with cancer: case reports and literature reviewE Castagnola, F Fioredda, M A Barretta, et al.
Bone Marrow Transplantation|May 22, 2001
Four year follow-up of a case of fucosidosis treated with unrelated donor bone marrow transplantationM Miano, E Lanino, R Gatti, et al.
Bone Marrow Transplantation|May 16, 2003
Mesial temporal sclerosis--a late complication in four allogeneic pediatric recipients with persistent seizures after an acute episode of cyclosporine-A neurotoxicityM Faraci, E Lanino, S Dallorso, et al.
Metabolism: Clinical and Experimental|April 1, 1994
Adenosine triphosphate release by osmotic shock and hemoglobin A1C in diabetic subjects' erythrocytesE Petruzzi, C Orlando, P Pinzani, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|March 1, 1995
[Sepsis in children with malignant neoplasia, equipped with a Broviac-type venous catheter]A Garaventa, E Castagnola, S Dallorso, et al.
Blood|July 15, 1995
Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormoneG Giorgiani, M Bozzola, F Locatelli, et al.
Medical and Pediatric Oncology|January 1, 1987
Resistant and relapsing neuroblastoma: improved response rate with a new multiagent regimen (OC-HDP) including high-dose cisplatinumG Dini, E Lanino, D Rogers, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|May 1, 1994
[High-dose chemotherapy, G-CSF and the use of peripheral blood progenitor cells in patients with poor-prognosis neuroblastoma]S Dallorso, L Rivabella, M Martinengo, et al.
Pageof 17